Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

539 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.
Cinque P, Brytting M, Vago L, Castagna A, Parravicini C, Zanchetta N, D'Arminio Monforte A, Wahren B, Lazzarin A, Linde A. Cinque P, et al. Among authors: wahren b. Lancet. 1993 Aug 14;342(8868):398-401. doi: 10.1016/0140-6736(93)92814-a. Lancet. 1993. PMID: 8101902
Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.
Calarota SA, Leandersson AC, Bratt G, Hinkula J, Klinman DM, Weinhold KJ, Sandström E, Wahren B. Calarota SA, et al. Among authors: wahren b. J Immunol. 1999 Aug 15;163(4):2330-8. J Immunol. 1999. PMID: 10438897
Immunoglobulin G abnormalities in HIV-1 infected individuals with lymphoma.
Lundholm P, Lucht E, Svedmyr E, Rudén U, Linde A, Wahren B. Lundholm P, et al. Among authors: wahren b. Immunotechnology. 1998 Jun;4(1):29-36. doi: 10.1016/s1380-2933(98)00003-7. Immunotechnology. 1998. PMID: 9661812
BACKGROUND: Polyclonal B-cell activation precedes the occurrence of malignant B-cell clones. Several recent reports suggest a perturbed cytokine regulation in HIV-related lymphomagenesis and Epstein-Barr virus (EBV) involvement in approximately half of the cases wit …
BACKGROUND: Polyclonal B-cell activation precedes the occurrence of malignant B-cell clones. Several recent reports suggest a …
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.
Broliden PA, Mäkitalo B, Akerblom L, Rosen J, Broliden K, Utter G, Jondal M, Norrby E, Wahren B. Broliden PA, et al. Among authors: wahren b. Immunology. 1991 Aug;73(4):371-6. Immunology. 1991. PMID: 1916888 Free PMC article.
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.
Bråve A, Gudmundsdotter L, Sandström E, Haller BK, Hallengärd D, Maltais AK, King AD, Stout RR, Blomberg P, Höglund U, Hejdeman B, Biberfeld G, Wahren B. Bråve A, et al. Among authors: wahren b. Vaccine. 2010 Nov 29;28(51):8203-9. doi: 10.1016/j.vaccine.2010.08.108. Epub 2010 Oct 15. Vaccine. 2010. PMID: 20951666 Free PMC article.
Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Bråve A, Hallengärd D, Schröder U, Blomberg P, Wahren B, Hinkula J. Bråve A, et al. Among authors: wahren b. Vaccine. 2008 Sep 19;26(40):5075-8. doi: 10.1016/j.vaccine.2008.03.066. Epub 2008 Apr 15. Vaccine. 2008. PMID: 18450334
Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.
Devito C, Zuber B, Schröder U, Benthin R, Okuda K, Broliden K, Wahren B, Hinkula J. Devito C, et al. Among authors: wahren b. J Immunol. 2004 Dec 1;173(11):7078-89. doi: 10.4049/jimmunol.173.11.7078. J Immunol. 2004. PMID: 15557206
Long-term humoral immunity was studied for up to 12 mo after the booster immunization by testing the presence of HIV-1 gp41- and CCR5-specific Abs and IgG/IgA-secreting B lymphocytes in spleen and regional lymph nodes in immunized mice. ...Intranasal DNA prime followed by …
Long-term humoral immunity was studied for up to 12 mo after the booster immunization by testing the presence of HIV-1 gp41- and CCR5-specif …
539 results
Jump to page
Feedback